Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters.
Stark FC, Akache B, Deschatelets L, Tran A, Stuible M, Durocher Y, McCluskie MJ, Agbayani G, Dudani R, Harrison BA, Renner TM, Makinen SR, Bavananthasivam J, Duque D, Gagne M, Zimmermann J, Zarley CD, Cochrane TR, Handfield M.
Stark FC, et al. Among authors: mccluskie mj.
Sci Rep. 2022 Jun 13;12(1):9772. doi: 10.1038/s41598-022-13819-5.
Sci Rep. 2022.
PMID: 35697917
Free PMC article.